ArticleFrontiers in microbiology2020
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive
Open access · goldAbstract read
In one paragraph
Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.
0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
83 citing papers in PubMed, 127 citations in OpenAlex.
- Safety and Immunogenicity of a Klebsiella pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A First-in-Human Phase I/II Randomized and Controlled Study.The Journal of infectious diseases · 2026Trial
- Characterization of a K62-specific phage depolymerase and its protective effect in a mouse model of Klebsiella pneumoniae infection.Folia microbiologica · 2026Article
- High exposure, rapid turnover: strain-level dynamics ofMicrobiology spectrum · 2026Article
- Cross-Serotype Protection of a PstS-YidR Fusion mRNA Vaccine Against Systemic Infection and Endogenous Endophthalmitis Caused by HypervirulentPathogens (Basel, Switzerland) · 2026Article
- A phage-based luminescent reporter platform for rapid typing of multiple capsular types ofhLife · 2026Article
- Effect of Structural Trimming on the Therapeutic Efficacy of K2 Capsule Depolymerase'sAntibiotics (Basel, Switzerland) · 2026Article
- Antimicrobial resistance and plasmidome of carbapenemase-resistant Klebsiella pneumoniae causing bloodstream infections between 2014 and 2024.BMC microbiology · 2026Article
- Clinical and Genomic Characterization of High-Risk Multidrug-ResistantMicroorganisms · 2026Article
- Genome-Wide Association of ST, K-, and O-Locus Diversity with Virulence in Indian Klebsiella pneumoniae via Targeted Phenotypic Validation.Current microbiology · 2026Article
- Article
- Modular Development of aNanomaterials (Basel, Switzerland) · 2026Article
- Multidrug-Resistant Pathogen Clonal Spread in Nigeria: A Systematic Review and Meta-Analysis.Health science reports · 2026Review
- O2a O-antigen type and sepsis in invasiveFrontiers in cellular and infection microbiology · 2026Article
- Genomic characterisation and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2026Article
- Variable progressive behavior ofFrontiers in immunology · 2026Article
- Epidemiological and Genomic Characteristics ofTransboundary and emerging diseases · 2026Article
- Antimicrobial Resistance, Virulence, and Genomic Characteristics ofTransboundary and emerging diseases · 2026Article
- Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens.Pathogens (Basel, Switzerland) · 2025Review
- Comparative genomic insights into multidrug resistance in classical and hypervirulent K. pneumoniae clinical isolates.Scientific reports · 2025Article
- Characterization of a Phage-Encoded Depolymerase AgainstViruses · 2025Article
23 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 18 institutions in 15 countries.
Myeongjin ChoiCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Nicolas HegerleCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Joseph NkezeCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Shaichi SenCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Sanchita JamindarCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Shamima NasrinCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Sunil SenCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Jasnehta Permala-BoothCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
James SinclairCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Milagritos D TapiaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States.
Sylla MamadouCentre pour le Développement des Vaccins, Bamako, Mali.
Joshua T ThadenDivision of Infectious Diseases, Duke University Medical Center, Durham, NC, United States.
Vance G FowlerDepartment of Medicine, Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, NC, United States.
Ana AguilarColegio de Ciencias de la Salud e Instituto de Microbiologia, Universidad San Francisco de Quito, Quito, Ecuador.
Enrique TeránColegio de Ciencias de la Salud e Instituto de Microbiologia, Universidad San Francisco de Quito, Quito, Ecuador.
Dominique DecreDépartement de Bactériologie, Centre d'Immunologie et des Maladies Infectieuses-Paris, Cimi-Paris, INSERM U1135, AP-HP, Sorbonne Université, Hôpitaux Universitaires Est Parisien, Paris, France.
Florence MorelDépartement de Bactériologie, Centre d'Immunologie et des Maladies Infectieuses-Paris, Cimi-Paris, INSERM U1135, AP-HP, Sorbonne Université, Hôpitaux Universitaires Est Parisien, Paris, France.
Karen Angeliki KrogfeltStatens Serum Institut, Copenhagen, Denmark.
Annelie BraunerDepartment of Microbiology, Tumor and Cell Biology, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Efthymia ProtonotariouDepartment of Microbiology, AHEPA University Hospital, Thessaloniki, Greece.
Eirini ChristakiDepartment of Medicine, AHEPA University Hospital, Thessaloniki, Greece.
Yuichiro ShindoDepartment of Respiratory Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Yi-Tsung LinDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Andrea L KwaDepartment of Pharmacy, Singapore General Hospital, Singapore, Singapore.
Sadia ShakoorDepartments of Pathology and Pediatrics, Aga Khan University, Karachi, Pakistan.
Ashika Singh-MoodleyNational Institute for Communicable Diseases, A Division of the National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Johannesburg, South Africa.
Olga PerovicNational Institute for Communicable Diseases, A Division of the National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Johannesburg, South Africa.
Jan JacobsDepartment of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Octavie LunguyaDepartment of Clinical Microbiology and Microbiology, National Institute for Biomedical Research, University Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo.
Raphael SimonCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Alan S CrossCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Sharon M TennantCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
University of Maryland, Baltimore · USAHEPA University Hospital · GRUniversidad San Francisco de Quito · ECAga Khan University · PKCentre Pour le Développement des Vaccins-Mali · MLClinical Research Institute · USDuke Medical Center · USInserm · FRInstituut voor Tropische Geneeskunde · BEKarolinska University Hospital · SENagoya University · JPNational Health Laboratory Service · ZANational Institute of Biomedical Research · CDNational Yang Ming Chiao Tung University · TWSingapore General Hospital · SGSorbonne Université · FRStatens Serum Institut · DKUniversity of the Witwatersrand · ZA
Funding
Institutional Career Development CoreKL2TR002554 · NCATS · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 2018 to 2022
$8.2MNCATS NIH HHS KL2 TR002554
Abstract
PubMed holds no abstract for this paper.
Indexed as
K antigenKlebsiella pneumoniaemultidrug resistanceO antigenvaccine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.